The Full Wiki

More info on CGP-37849

CGP-37849: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

Systematic (IUPAC) name
(E,2R)-2-amino-4-methyl-5-phosphonopent-3-enoic acid
CAS number 137424-81-8
ATC code  ?
PubChem 5950212
Chemical data
Formula C 6H12NO5P 
Mol. mass 209.137 g/mol
SMILES eMolecules & PubChem
Synonyms CGP-37849, CGP-40116
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status
Routes  ?

CGP-37849 is a competitive antagonist at the NMDA receptor.[1] It is a potent, orally active anticonvulsant in animal models,[2] and was researched for the treatment of epilepsy.[3] It also has neuroprotective activity[4] and shows antidepressant[5][6] and anxiolytic effects.[7][8]


  1. ^ Fagg GE, Olpe HR, Pozza MF, Baud J, Steinmann M, Schmutz M, Portet C, Baumann P, Thedinga K, Bittiger H, et al. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity. British Journal of Pharmacology. 1990 Apr;99(4):791-7. PMID 1972895
  2. ^ Schmutz M, Portet C, Jeker A, Klebs K, Vassout A, Allgeier H, Heckendorn R, Fagg GE, Olpe HR, van Riezen H. The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents. Naunyn-Schmiedebergs Archives of Pharmacology. 1990 Jul;342(1):61-6. PMID 1976233
  3. ^ Fujikawa DG, Daniels AH, Kim JS. The competitive NMDA receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage. Epilepsy Research. 1994 Mar;17(3):207-19. PMID 7912191
  4. ^ Gutnikov SA, Gaffan D. Systemic NMDA receptor antagonist CGP-40116 does not impair memory acquisition but protects against NMDA neurotoxicity in rhesus monkeys. Journal of Neuroscience. 1996 Jun 15;16(12):4041-5. PMID 8656297
  5. ^ Maj J, Klimek V, Gołembiowska K, Rogóz Z, Skuza G. Central effects of repeated treatment with CGP 37849, a competitive NMDA receptor antagonist with potential antidepressant activity. Polish Journal of Pharmacology. 1993 Sep-Dec;45(5-6):455-66. PMID 7912134
  6. ^ Papp M, Moryl E. Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. European Journal of Pharmacology. 1994 Sep 22;263(1-2):1-7. PMID 7821340
  7. ^ Jessa M, Nazar M, Bidzinski A, Plaznik A. The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety. European Neuropsychopharmacology. 1996 Mar;6(1):55-61. PMID 8866939
  8. ^ Przegaliński E, Tatarczyńska E, Chojnacka-Wójcik E. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats. Neuropharmacology. 2000 Jul 24;39(10):1858-64. PMID 10884566


Got something to say? Make a comment.
Your name
Your email address